Jack Nathan Medical Stock Short Ratio
| JNHMF Stock | USD 0.03 0.00 0.00% |
Jack Nathan Medical fundamentals help investors to digest information that contributes to Jack Nathan's financial success or failures. It also enables traders to predict the movement of Jack OTC Stock. The fundamental analysis module provides a way to measure Jack Nathan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jack Nathan otc stock.
Jack |
Jack Nathan Medical OTC Stock Short Ratio Analysis
Jack Nathan's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Jack Nathan Medical has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Jack Fundamentals
| Return On Equity | -1.78 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | (0.30) % | |||
| Current Valuation | 6.84 M | |||
| Shares Outstanding | 84.33 M | |||
| Shares Owned By Insiders | 41.27 % | |||
| Price To Book | 4.55 X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 9.64 M | |||
| Gross Profit | 6.66 M | |||
| EBITDA | (7.54 M) | |||
| Net Income | (7.81 M) | |||
| Cash And Equivalents | 816.49 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 106.58 K | |||
| Debt To Equity | 0.88 % | |||
| Current Ratio | 0.47 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (4.34 M) | |||
| Earnings Per Share | (0.08) X | |||
| Beta | -1.43 | |||
| Market Capitalization | 5.68 M | |||
| Total Asset | 8.14 M | |||
| Z Score | 32.8 | |||
| Net Asset | 8.14 M |
About Jack Nathan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jack Nathan Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jack Nathan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jack Nathan Medical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Jack OTC Stock
Jack Nathan financial ratios help investors to determine whether Jack OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jack with respect to the benefits of owning Jack Nathan security.